Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease
Authors:
- Mark B. RothMRMark B. Roth
- Kimberly DreierKDKimberly Dreier
- Anthony F. JohnsonAJAnthony F. Johnson
- Melissa Palmer-DensmoreMPMelissa Palmer-Densmore
- Kris SimmonsKSKris Simmons
- Robert FantonRFRobert Fanton
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The immunology of companion animals: reagents and therapeutic strategies with potential veterinary and human clinical applicationsImmunology Today, 1994
- Preparation of anti-canine serum amyloid A (SAA) serum and purification of SAA from canine high-density lipoproteinVeterinary Immunology and Immunopathology, 1994
- Monoclonal antibodies that define canine homologues of human CD antigens: Summary of the First International Canine Leukocyte Antigen Workshop (CLAW)Tissue Antigens, 1994
- The acute phase responseImmunology Today, 1994
- Acute Phase Protein, Serum Amyloid A, Inhibits IL‐1‐ and TNF‐Induced Fever and Hypothalamic PGE2 in MiceScandinavian Journal of Immunology, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.Journal of Experimental Medicine, 1990
- Anti‐interferon‐γ antibody protects mice against the generalized Shwartzman reactionEuropean Journal of Immunology, 1987
- Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.Journal of Clinical Investigation, 1985
- Experimental challenge of dogs with canine parvovirus-21980